協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/07/29 | 3,185 | 3,185 | 3,125 | 3,130 | -40 | -1.3% | 678,000 |
| 2022/07/28 | 3,175 | 3,185 | 3,115 | 3,170 | -30 | -0.9% | 721,000 |
| 2022/07/27 | 3,180 | 3,230 | 3,175 | 3,200 | +40 | +1.3% | 645,500 |
| 2022/07/26 | 3,165 | 3,180 | 3,155 | 3,160 | -40 | -1.3% | 369,900 |
| 2022/07/25 | 3,185 | 3,210 | 3,155 | 3,200 | +25 | +0.8% | 591,300 |
| 2022/07/22 | 3,195 | 3,205 | 3,145 | 3,175 | -30 | -0.9% | 516,800 |
| 2022/07/21 | 3,165 | 3,205 | 3,150 | 3,205 | ±0 | ±0% | 625,800 |
| 2022/07/20 | 3,185 | 3,220 | 3,170 | 3,205 | +55 | +1.7% | 627,800 |
| 2022/07/19 | 3,180 | 3,200 | 3,110 | 3,150 | -65 | -2% | 769,200 |
| 2022/07/15 | 3,250 | 3,255 | 3,175 | 3,215 | -45 | -1.4% | 1,118,600 |
| 2022/07/14 | 3,225 | 3,275 | 3,220 | 3,260 | +40 | +1.2% | 861,800 |
| 2022/07/13 | 3,300 | 3,300 | 3,205 | 3,220 | +45 | +1.4% | 845,200 |
| 2022/07/12 | 3,170 | 3,210 | 3,155 | 3,175 | +10 | +0.3% | 733,500 |
| 2022/07/11 | 3,185 | 3,200 | 3,160 | 3,165 | +35 | +1.1% | 527,700 |
| 2022/07/08 | 3,180 | 3,185 | 3,110 | 3,130 | -50 | -1.6% | 1,009,600 |
| 2022/07/07 | 3,185 | 3,190 | 3,140 | 3,180 | +65 | +2.1% | 748,600 |
| 2022/07/06 | 3,105 | 3,155 | 3,100 | 3,115 | ±0 | ±0% | 646,500 |
| 2022/07/05 | 3,120 | 3,150 | 3,095 | 3,115 | +35 | +1.1% | 807,800 |
| 2022/07/04 | 3,065 | 3,095 | 3,035 | 3,080 | +45 | +1.5% | 576,900 |
| 2022/07/01 | 3,060 | 3,080 | 3,020 | 3,035 | -15 | -0.5% | 757,200 |
| 2022/06/30 | 3,080 | 3,105 | 3,045 | 3,050 | -5 | -0.2% | 1,199,000 |
| 2022/06/29 | 3,040 | 3,060 | 3,020 | 3,055 | -50 | -1.6% | 1,708,900 |
| 2022/06/28 | 3,070 | 3,115 | 3,045 | 3,105 | +25 | +0.8% | 759,100 |
| 2022/06/27 | 3,095 | 3,100 | 3,045 | 3,080 | -10 | -0.3% | 593,900 |
| 2022/06/24 | 3,075 | 3,095 | 3,050 | 3,090 | +65 | +2.1% | 1,133,600 |
| 2022/06/23 | 3,005 | 3,065 | 3,005 | 3,025 | +25 | +0.8% | 856,500 |
| 2022/06/22 | 2,945 | 3,020 | 2,936 | 3,000 | +70 | +2.4% | 835,800 |
| 2022/06/21 | 2,954 | 2,983 | 2,923 | 2,930 | +6 | +0.2% | 998,000 |
| 2022/06/20 | 2,854 | 2,932 | 2,851 | 2,924 | +101 | +3.6% | 1,202,300 |
| 2022/06/17 | 2,807 | 2,835 | 2,777 | 2,823 | +15 | +0.5% | 1,321,500 |
| 2022/06/16 | 2,869 | 2,869 | 2,803 | 2,808 | -14 | -0.5% | 676,800 |
| 2022/06/15 | 2,879 | 2,887 | 2,817 | 2,822 | -49 | -1.7% | 1,252,300 |
| 2022/06/14 | 2,807 | 2,888 | 2,801 | 2,871 | +21 | +0.7% | 1,181,500 |
| 2022/06/13 | 2,895 | 2,916 | 2,843 | 2,850 | -90 | -3.1% | 1,142,100 |
| 2022/06/10 | 2,896 | 2,977 | 2,892 | 2,940 | +94 | +3.3% | 2,258,100 |
| 2022/06/09 | 2,842 | 2,873 | 2,838 | 2,846 | +5 | +0.2% | 586,200 |
| 2022/06/08 | 2,794 | 2,850 | 2,772 | 2,841 | +86 | +3.1% | 723,600 |
| 2022/06/07 | 2,757 | 2,773 | 2,738 | 2,755 | -4 | -0.1% | 752,300 |
| 2022/06/06 | 2,736 | 2,779 | 2,723 | 2,759 | +13 | +0.5% | 526,000 |
| 2022/06/03 | 2,793 | 2,793 | 2,735 | 2,746 | -8 | -0.3% | 783,200 |
| 2022/06/02 | 2,790 | 2,790 | 2,730 | 2,754 | -37 | -1.3% | 555,000 |
| 2022/06/01 | 2,782 | 2,839 | 2,773 | 2,791 | +14 | +0.5% | 681,500 |
| 2022/05/31 | 2,797 | 2,813 | 2,752 | 2,777 | -20 | -0.7% | 2,496,900 |
| 2022/05/30 | 2,742 | 2,810 | 2,721 | 2,797 | +67 | +2.5% | 1,777,300 |
| 2022/05/27 | 2,710 | 2,735 | 2,684 | 2,730 | +55 | +2.1% | 896,000 |
| 2022/05/26 | 2,720 | 2,755 | 2,673 | 2,675 | -50 | -1.8% | 1,009,600 |
| 2022/05/25 | 2,743 | 2,749 | 2,712 | 2,725 | -9 | -0.3% | 818,300 |
| 2022/05/24 | 2,750 | 2,754 | 2,707 | 2,734 | -38 | -1.4% | 1,027,300 |
| 2022/05/23 | 2,750 | 2,780 | 2,731 | 2,772 | +65 | +2.4% | 675,000 |
| 2022/05/20 | 2,727 | 2,744 | 2,699 | 2,707 | -45 | -1.6% | 1,104,900 |
751～
800
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 263,500円 | -3.5% | -11.3% | 2.28% | 24.20倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 168,300円 | +0.9% | +380.2% | 4.63% | 23.19倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 260,400円 | +20.9% | +10.6% | 2.53% | 12.31倍 | 1.62倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 465,100円 | +0.1% | -3.4% | 3.44% | 31.62倍 | 1.56倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 165,000円 | +0.6% | +43.3% | 4.85% | 11.57倍 | 0.99倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
